InvestorsHub Logo
Followers 43
Posts 5537
Boards Moderated 0
Alias Born 11/15/2013

Re: TheDane post# 289608

Wednesday, 04/01/2020 1:57:56 PM

Wednesday, April 01, 2020 1:57:56 PM

Post# of 403545
Barda results check. Now waiting word on second MTA university testing.

"Should laboratory tests support Brilacidin’s antiviral activity against SARS-CoV-2 (COVID-19), and potentially other RNA viruses, the Company will look to expedite research and clinical development of Brilacidin as a potential antiviral therapy via pharmaceutical partnerships, academic collaborations and government grants".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News